Epidemiology of multiple sclerosis in iran: A systematic review

European Neurology

Volumn 70, Issue 5-6, 2013, Pages 356-363

  Etemadifar, Masoud ^a,b   Sajjadi, Sepideh ^b,c   Nasr, Zahra ^b,c   Firoozeei, Toktam Sadat ^b   Abtahi, Seyed Hossein ^b,c   Akbari, Mojtaba ^d   Fereidan Esfahani, Mahboobeh ^b,c,e  

^a Medical School   (Iran)

^b Isfahan Research Committee of Multiple Sclerosis (IRCOMS)   (Iran)

^c LORESTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e Sadi Hospital   (Iran)

Author keywords

Epidemiology; Incidence; Iran; Multiple sclerosis; Prevalence

Indexed keywords

ANALGESIA (SENSORY DYSFUNCTION); DATA BASE; EMBASE; ENVIRONMENTAL FACTOR; ETHNICITY; HUMAN; INCIDENCE; IRAN; MEDLINE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; RELAPSE; REVIEW; SYSTEMATIC REVIEW; FACTUAL DATABASE; GENETICS; PREVALENCE; SECONDARY PREVENTION; SEX DIFFERENCE; AFGHANISTAN; AZERBAIJAN; EXPANDED DISABILITY STATUS SCALE; FAMILY HISTORY; IMMIGRATION; PAKISTAN; POPULATION RESEARCH; VISUAL DISORDER; VISUAL IMPAIRMENT;

DATABASES, FACTUAL; HUMANS; INCIDENCE; IRAN; MULTIPLE SCLEROSIS; PREVALENCE; SECONDARY PREVENTION; SEX FACTORS;

EID: 84886735734     PISSN: 00143022     EISSN: 14219913     Source Type: Journal    
DOI: 10.1159/000355140     Document Type: Review

References (37)

1. Frohman EM, Racke MK, Raine CS: Multiple sclerosis -the plaque and its pathogenesis. N Engl J Med 2006; 354: 942-955.
2. Kurtzke JF: Epidemiologic contributions to multiple sclerosis: an overview. Neurology 1980; 30: 61-79. (Pubitemid 10033848)
3. Kurtzke JF: A reassessment of the distribution of multiple sclerosis. Acta Neurol Scand 1975; 51: 137-157.
4. Benamer HT, Ahmed ES, Al-Din AS, Grosset DG: Frequency and clinical patterns of multiple sclerosis in Arab countries: a systematic review. J Neurol Sci 2009; 278: 1-4.
5. Pakpoor J, Ramagopalan S: Multiple sclerosis and the Iranian revolution: reply to the comment by Magzhi et al. Neuroepidemiology 2012; 40: 70.
6. Etemadifar M, Abtahi SH: Multiple sclerosis in Isfahan, Iran: past, present and future. Int J Prev Med 2012; 3: 301-302.
7. Maghzi AH, Sahraian MA, Shaygannejad V, Minagar A: Is the Iranian revolution to blame for the increasing incidence of multiple sclerosis in Iran? Neuroepidemiology 2012; 40: 68-69.
8. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW: New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227-231. (Pubitemid 13158528)
9. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BY, Wolinsky JS: Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50: 121-127.
10. Sahraian MA, Khorramnia S, Ebrahim MM, Moinfar Z, Lotfi J, Pakdaman H: Multiple sclerosis in Iran: a demographic study of 8,000 patients and changes over time. Eur Neurol 2010; 64: 331-336.
11. Elhami SR, Mohammad K, Sahraian MA, Eftekhar H: A 20-year incidence trend (1989-2008) and point prevalence (March 20, 2009) of multiple sclerosis in Tehran, Iran: a population-based study. Neuroepidemiology 2011; 36: 141-147.
12. Heydarpour P, Mohammad K, Yekaninejad MS, Elhami SR, Khoshkish S, Sahraian MA: Multiple sclerosis in Tehran, Iran: a Joinpoint trend analysis. Mult Scler (E-pub ahead of print).
13. Etemadifar M, Janghorbani M, Shaygannejad V, Ashtari F: Prevalence of multiple sclerosis in Isfahan, Iran. Neuroepidemiology 2006; 27: 39-44. (Pubitemid 44114410)
14. Saadatnia M, Etemadifar M, Maghzi AH: Multiple sclerosis in Isfahan, Iran. Int Rev Neurobiol 2007; 79: 357-375.
15. Etemadifar M, Maghzi AH: Sharp increase in the incidence and prevalence of multiple sclerosis in Isfahan, Iran. Mult Scler 2011; 17: 1022-1027.
16. Ghandehari K, Riasi HR, Nourian A, Boroumand AR: Prevalence of multiple sclerosis in north east of Iran. Mult Scler 2010; 16: 1525-1526.
17. Abedini M, Habibi-Saravi R, Zarvani A, Farahmand M: Epidemiology of multiple sclerosis in Mazandran province in 2007 (in Persian). J Mazandaran Univ Med Sci 2008; 18: 82-87.
18. Hashemilar M, Savadi Ouskui D, Farhoudi M, Ayromlou H, Asadollahi A: Multiple sclerosis in east Azerbaijan, north west Iran. Neurology Asia 2011; 16: 127-131.
19. Moghtaderi A, Rakhshanizadeh F, Shahraki-Ibrahimi S: Incidence and prevalence of multiple sclerosis in southeastern Iran. Clin Neurol Neurosurg 2013; 115: 304-308.
20. Sharafaddinzadeh N, Moghtaderi A, Majdinasab N, Dahmardeh M, Kashipazha D, Shalbafan B: The influence of ethnicity on the characteristics of multiple sclerosis: a local population study between Persians and Arabs. Clin Neurol Neurosurg 2013; 115: 1271-1275.
21. Maghzi AH, Marta M, Bosca I, Etemadifar M, Dobson R, Maggiore C, Giovannoni G, Meier UC: Viral pathophysiology of multiple sclerosis: a role for Epstein-Barr virus infection? Pathophysiology 2011; 18: 13-20.
22. Alonso A, Cook SD, Maghzi AH, Divani AA: A case-control study of risk factors for multiple sclerosis in Iran. Mult Scler 2011; 17: 550-555.
23. Maghzi AH, Ghazavi H, Ahsan M, Etemadifar M, Mousavi S, Khorvash F, Minagar A: Increasing female preponderance of multiple sclerosis in Isfahan, Iran: a population-based study. Mult Scler 2010; 16: 359-361.
24. El-Salem K, Al-Shimmery E, Horany K, Al-Refai A, Al-Hayk K, Khader Y: Multiple sclerosis in Jordan: a clinical and epidemiological study. J Neurol 2006; 253: 1210-1216. (Pubitemid 44511480)
25. Tanaka K, Kujuro Y, Suzuki S, Tanahashi N, Hamada J, Nogawa S, Suzuki N: Clinical and laboratory features of in-patients with multiple sclerosis in a University Hospital in Tokyo from 1988 to 2002. Intern Med 2005; 44: 560-566. (Pubitemid 40932828)
26. Farjadian S, Naruse T, Kawata H, Ghaderi A, Bahram S, Inoko H: Molecular analysis of HLA allele frequencies and haplotypes in Baloch of Iran compared with related populations of Pakistan. Tissue Antigens 2004; 64: 581-587. (Pubitemid 39472923)
27. Wasay M, Ali S, Khatri IA, Hassan A, Asif M, Zakiullah N, Ahmed A, Malik A, Khealani B, Haq A, Fredrikson S: Multiple sclerosis in Pakistan. Mult Scler 2007; 13: 668-669. (Pubitemid 46939535)
28. Maghzi AH, Sahraian MA, Maghzi H, Shaygannejad V: Multiple sclerosis in Sistan and Baloochestan, south east Iran. Clin Neurol Neurosurg 2013; 115: 847-848.
29. Hakobyan ME, Angelova IB, Manvelyan HML: Comprehensive epidemiology of multiple sclerosis in Europe and Armenia: hidden pandemics? New Armenian Med J 2008; 2: 6-13.
30. Farjadian S, Ghaderi A: HLA class II genetic diversity in Arabs and Jews of Iran. Iran J Immunol 2007; 4: 85-93. (Pubitemid 46983398)
31. Fereidan-Esfahani M, Abtahi SH, Nourian SM, Etemadifar M: Multiple sclerosis among Iranian-Arabs and Persians of Khuzestan: is there any ethnic difference? Clin Neurol Neurosurg 2013 (E-pub ahead of print).
32. Kurtzke JF: A reassessment of the distribution of multiple sclerosis. Part 1. Acta Neurol Scand 1975; 51: 110-136.
33. Hovsepian S, Amini M, Aminorroaya A, Amini P, Iraj B: Prevalence of vitamin D deficiency among adult population of Isfahan City, Iran. J Health Popul Nutr 2011; 29: 149-155.
34. Moussavi M, Heidarpour R, Aminorroaya A, Pournaghshband Z, Amini M: Prevalence of vitamin D deficiency in Isfahani high school students in 2004. Horm Res 2005; 64: 144-148. (Pubitemid 41507297)
35. Rabbani A, Alavian SM, Motlagh ME, Ashtiani MT, Ardalan G, Salavati A, Rabbani B, Shams S, Parvaneh N: Vitamin D insufficiency among children and adolescents living in Tehran, Iran. J Trop Pediatr 2009; 55: 189-191.
36. Guzel R, Kozanoglu E, Guler-Uysal F, Soyupak S, Sarpel T: Vitamin D status and bone mineral density of veiled and unveiled Turkish women. J Womens Health Gend Based Med 2001; 10: 765-770. (Pubitemid 33062086)
37. Pakpoor J, Ramagopalan SV: Multiple sclerosis and the Iranian revolution. Neuroepidemiology 2012; 38: 122.